383 related articles for article (PubMed ID: 18630459)
1. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
Hochster HS; Luo W; Popa EC; Lyman BT; Mulcahy M; Beatty PA; Benson AB
J Clin Oncol; 2007 Dec; 25(34):5397-402. PubMed ID: 18048821
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C
Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713
[TBL] [Abstract][Full Text] [Related]
5. Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.
Hsiao SC; Lin JF; Chuang MT; Lee YA; Wu DL
Int Surg; 2009; 94(4):298-303. PubMed ID: 20302025
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
Mizushima T; Mizuno H; Ito T; Hoki M; Souma Y; Iwamoto T; Ozawa H; Kanou T; Nakamori Y; Iwase K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):941-4. PubMed ID: 16835484
[TBL] [Abstract][Full Text] [Related]
7. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N
J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Carmichael J; Popiela T; Radstone D; Falk S; Borner M; Oza A; Skovsgaard T; Munier S; Martin C
J Clin Oncol; 2002 Sep; 20(17):3617-27. PubMed ID: 12202662
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
11. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
Lin PC; Chen WS; Chao TC; Yang SH; Tiu CM; Liu JH
Cancer Chemother Pharmacol; 2007 Aug; 60(3):351-6. PubMed ID: 17111120
[TBL] [Abstract][Full Text] [Related]
12. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
Nogué M; Salud A; Batiste-Alentorn E; Saigí E; Losa F; Cirera L; Méndez M; Campos JM; Galan A; Escudero P; Arcusa A; Manzano H; de Mendizábal EV; de Olaguer JP; Boleda M; Guasch I; Vicente P
Eur J Cancer; 2005 Oct; 41(15):2241-9. PubMed ID: 16214045
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC
Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795
[TBL] [Abstract][Full Text] [Related]
14. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Douillard JY; Hoff PM; Skillings JR; Eisenberg P; Davidson N; Harper P; Vincent MD; Lembersky BC; Thompson S; Maniero A; Benner SE
J Clin Oncol; 2002 Sep; 20(17):3605-16. PubMed ID: 12202661
[TBL] [Abstract][Full Text] [Related]
15. [Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
Hasegawa S; Matsumoto S; Kawashima K; Fujii H; Hatano E; Satoh S; Ikai I; Shimahara Y
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1045-9. PubMed ID: 16044971
[TBL] [Abstract][Full Text] [Related]
16. [Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer].
Sakuyama T; Yokoyama M; Ogawa M; Takao Y; Sato K; Kawahara H; Anazawa S; Yamazaki Y; Hirai K
Gan To Kagaku Ryoho; 2004 May; 31(5):771-5. PubMed ID: 15170991
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
Toyokawa A; Tsujimura T; Hamabe Y; Sato S; Mukubou H; Wakahara T; Kaji M; Tsukamoto T; Wakita K; Onishi N; Ishida T; Watanabe A; Fujiwara H; Mukai H
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2087-90. PubMed ID: 16352933
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
19. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
[TBL] [Abstract][Full Text] [Related]
20. [Compliance of oral UFT plus leucovorin adjuvant chemotherapy in patients who underwent curative resection for colorectal cancer].
Tsunoda A; Nakao K; Watanabe M
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1065-8. PubMed ID: 20567109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
